DHG Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
DHG Pharmaceutical has a total shareholder equity of ₫4,409.5B and total debt of ₫1,155.2B, which brings its debt-to-equity ratio to 26.2%. Its total assets and total liabilities are ₫6,253.3B and ₫1,843.7B respectively. DHG Pharmaceutical's EBIT is ₫866.7B making its interest coverage ratio -6.8. It has cash and short-term investments of ₫2,836.4B.
Key information
26.2%
Debt to equity ratio
₫1.16t
Debt
| Interest coverage ratio | -6.8x |
| Cash | ₫2.84t |
| Equity | ₫4.41t |
| Total liabilities | ₫1.84t |
| Total assets | ₫6.25t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DHG's short term assets (₫4,833.8B) exceed its short term liabilities (₫1,774.1B).
Long Term Liabilities: DHG's short term assets (₫4,833.8B) exceed its long term liabilities (₫69.6B).
Debt to Equity History and Analysis
Debt Level: DHG has more cash than its total debt.
Reducing Debt: DHG's debt to equity ratio has increased from 7.3% to 26.2% over the past 5 years.
Debt Coverage: DHG's debt is well covered by operating cash flow (86.8%).
Interest Coverage: DHG earns more interest than it pays, so coverage of interest payments is not a concern.